Vanguard Personalized Indexing Management’s Twist Bioscience TWST Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$931K	Buy	9,051 +694	+8%	+$45.2K	0.01%	1039
2026 Q1	$397K	Buy	+8,357	New	+$375K	﹤0.01%	1445
2025 Q3	–	Sell	-6,031	Closed	-$222K	–	2051
2025 Q2	$222K	Buy	6,031 +469	+8%	+$16.2K	﹤0.01%	1583
2025 Q1	$218K	Sell	5,562 -304	-5%	-$13.7K	﹤0.01%	1482
2024 Q4	$273K	Buy	5,866 +907	+18%	+$41K	﹤0.01%	1381
2024 Q3	$224K	Buy	+4,959	New	+$236K	﹤0.01%	1480
2021 Q3	–	Sell	-1,732	Closed	-$231K	–	1055
2021 Q2	$231K	Buy	+1,732	New	+$201K	0.02%	850

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Personalized Indexing Management's TWST Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Twist Bioscience (TWST) stake by 8.3% in Q2 2026, buying an estimated $45.2K and bringing the position to 9,051 shares worth $931K. The position accounts for 0.01% of the portfolio, ranked #1039.

Vanguard Personalized Indexing Management first reported a position in TWST in Q2 2021 and has held it in 7 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Vanguard Personalized Indexing Management held 9,051 shares of Twist Bioscience worth $931K as of Q2 2026.
Vanguard Personalized Indexing Management bought 694 Twist Bioscience shares in Q2 2026, an estimated $45.2K.
Twist Bioscience made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1039 holding.
Vanguard Personalized Indexing Management first reported a position in Twist Bioscience in Q2 2021 and has held it in 7 quarters since.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.